{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:17:49Z","timestamp":1792801069395,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Turku Doctoral Programme of Molecular Medicine, University of Turku","id":[{"id":"https:\/\/ror.org\/05vghhr25","id-type":"ROR","asserted-by":"crossref"}]},{"name":"InFLAMES Flagship doctoral module"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HD040364, HD042444, HD051997"],"award-info":[{"award-number":["HD040364, HD042444, HD051997"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC 677943"],"award-info":[{"award-number":["ERC 677943"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["955321"],"award-info":[{"award-number":["955321"]}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["310561, 314443, 329278, 335434, 335611, 341342"],"award-info":[{"award-number":["310561, 314443, 329278, 335434, 335611, 341342"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["250114, 292335, 294337, 292482, 319280, 329277, 331793, 335435, 31444"],"award-info":[{"award-number":["250114, 292335, 294337, 292482, 319280, 329277, 331793, 335435, 31444"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sigrid Juselius Foundation","id":[{"id":"https:\/\/ror.org\/00ckakm23","id-type":"ROR","asserted-by":"crossref"}]},{"name":"InFLAMES Flagship Programme","award":["337530"],"award-info":[{"award-number":["337530"]}]},{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ELIXIR Finland"},{"name":"Breakthrough T1D Foundation","id":[{"id":"https:\/\/ror.org\/00vqxjy61","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0057218"],"award-info":[{"award-number":["NNF19OC0057218"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Finnish Cancer Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>T cells play a pivotal role in the autoimmune destruction of beta cells in type 1 diabetes. However, our understanding of the disease has been limited by lack of a comprehensive single-cell transcriptome analysis of T cells during its early stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed single cell RNA sequencing analysis of 73 longitudinal CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell samples collected at an early age of 3\u201324 months from children who subsequently developed type 1 diabetes (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200911) and their matched controls (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200911). The samples analysed here were at or before the age of seroconversion, i.e., appearance of beta cell specific autoantibodies. These samples were obtained from the Trial to Reduce Insulin Dependent Diabetes Mellitus (IDDM) in Genetically at Risk (TRIGR) study (ClincalTrials.gov ID: NCT00179777).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      By phenotypically characterizing over 99,000 cells, we identified cell-type-specific gene expression patterns associated with disease progression. While the cell-type compositions were similar, several genes were differentially regulated in cases in different cell types. Besides pathways altered in cases in specific cell types, interferon related pathways and pathways related to viral response were altered in multiple cell types in cases. We also identified gene regulatory networks (regulon) that drives the transcriptional state of the cell types. Notably, we observed increased\n                      <jats:italic>PRDM1<\/jats:italic>\n                      regulon activity in Th17 cells and diminished\n                      <jats:italic>GATA3<\/jats:italic>\n                      regulon activity in na\u00efve T cells, among other changes in the activity of different regulons in children progressing to disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings reveal early, cell-type-specific changes in transcription and gene regulatory networks in CD4\u207a T cells associated with type 1 diabetes progression, highlighting key pathways and transcriptional regulators. These insights provide a foundation for understanding early immune dysregulation in type 1 diabetes and basis for strategies to develop early diagnosis and intervention\n                      <jats:bold>.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-025-01574-x","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:15:54Z","timestamp":1767050154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Single-cell RNA-seq analysis of longitudinal CD4+ T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes"],"prefix":"10.1186","volume":"17","author":[{"given":"Rahul","family":"Biradar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaid Ullah","family":"Kalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"L\u00f6nnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini","family":"Junttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Suomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n Z\u00fa\u00f1iga","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Starskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Paulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Mikkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Vaarala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Elo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lahesmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2337\/dc20-1836","volume":"44","author":"V Anand","year":"2021","unstructured":"Anand V, et al. Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S. Diabetes Care. 2021;44:2269\u201376.","journal-title":"Diabetes Care"},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309:2473\u20139.","journal-title":"JAMA"},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.2337\/db13-1777","volume":"63","author":"RC Ferreira","year":"2014","unstructured":"Ferreira RC, et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes. 2014;63:2538\u201350.","journal-title":"Diabetes"},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/db13-1775","volume":"63","author":"H Kallionp\u00e4\u00e4","year":"2014","unstructured":"Kallionp\u00e4\u00e4 H, et al. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes. 2014;63:2402\u201314.","journal-title":"Diabetes"},{"key":"1574_CR5","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2337\/db14-0983","volume":"64","author":"R Moulder","year":"2015","unstructured":"Moulder R, et al. Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility. Diabetes. 2015;64:2265\u201378.","journal-title":"Diabetes"},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/db21-0612","volume":"71","author":"NG Bediaga","year":"2022","unstructured":"Bediaga NG, et al. Cytotoxicity-Related Gene Expression and Chromatin Accessibility Define a Subset of CD4+ T Cells That Mark Progression to Type 1 Diabetes. Diabetes. 2022;71:556\u201377.","journal-title":"Diabetes"},{"key":"1574_CR7","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.2337\/db19-0287","volume":"68","author":"H Kallionp\u00e4\u00e4","year":"2019","unstructured":"Kallionp\u00e4\u00e4 H, et al. Early detection of peripheral blood cell signature in children developing \u03b2-cell autoimmunity at a young age. Diabetes. 2019;68:2024\u201334.","journal-title":"Diabetes"},{"key":"1574_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-024-01300-z","volume":"16","author":"MA Honardoost","year":"2024","unstructured":"Honardoost MA, et al. Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes. Genome Med. 2024;16:1\u201324.","journal-title":"Genome Med"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3164\/jcbn.24-86","volume":"76","author":"T Okamura","year":"2025","unstructured":"Okamura T, et al. Single-cell analysis reveals islet autoantigen\u2019s immune activation in type 1 diabetes patients. J Clin Biochem Nutr. 2025;76:64\u201384.","journal-title":"J Clin Biochem Nutr"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38:1964\u201374.","journal-title":"Diabetes Care"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1399-5448.2007.00239.x","volume":"8","author":"J Krischer","year":"2007","unstructured":"Krischer J, et al. Study design of the tial to reduce IDDM in the genetically at risk (TRIGR). Pediatr Diabetes. 2007;8:117\u201337.","journal-title":"Pediatr Diabetes"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KGMM Alberti","year":"1998","unstructured":"Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539\u201353.","journal-title":"Diabet Med"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.2337\/diab.41.12.1570","volume":"41","author":"CJ Greenbaum","year":"1992","unstructured":"Greenbaum CJ, et al. Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes. 1992;41:1570\u20134.","journal-title":"Diabetes"},{"key":"1574_CR14","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1001\/jama.2014.5610","volume":"311","author":"M Knip","year":"2014","unstructured":"Knip M, et al. Hydrolyzed infant formula and early \u03b2-cell autoimmunity: a randomized clinical trial. JAMA. 2014;311:2279\u201387.","journal-title":"JAMA"},{"key":"1574_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2337\/dc12-0445","volume":"36","author":"A Parkkola","year":"2013","unstructured":"Parkkola A, H\u00e4rk\u00f6nen T, Ryh\u00e4nen SJ, Ilonen J, Knip M. Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children. Diabetes Care. 2013;36:348\u201354.","journal-title":"Diabetes Care"},{"key":"1574_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jama.2017.19826","volume":"319","author":"Writing Group for the TRIGR Study Group","year":"2018","unstructured":"Writing Group for the TRIGR Study Group. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial. JAMA. 2018;319:38\u201348.","journal-title":"JAMA"},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-018-1603-1","volume":"19","author":"M Stoeckius","year":"2018","unstructured":"Stoeckius M, et al. Cell hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 2018;19:1\u201312.","journal-title":"Genome Biol"},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-3587.e29.","journal-title":"Cell"},{"key":"1574_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188746","author":"MD Luecken","year":"2019","unstructured":"Luecken MD, Theis FJ. Current best practices in single-cell RNA-seq analysis: a tutorial. Mol Syst Biol. 2019. https:\/\/doi.org\/10.15252\/msb.20188746.","journal-title":"Mol Syst Biol"},{"key":"1574_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0888-1","volume":"17","author":"T Ilicic","year":"2016","unstructured":"Ilicic T, et al. Classification of low quality cells from single-cell RNA-seq data. Genome Biol. 2016;17:1\u201315.","journal-title":"Genome Biol"},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888-1902.e21.","journal-title":"Cell"},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19894-4","volume":"11","author":"HL Crowell","year":"2020","unstructured":"Crowell HL, et al. Muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. Nat Commun. 2020;11:1\u201312.","journal-title":"Nat Commun"},{"key":"1574_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1005562","volume":"13","author":"T Suomi","year":"2017","unstructured":"Suomi T, Seyednasrollah F, Jaakkola MK, Faux T, Elo LL. ROTS: an R package for reproducibility-optimized statistical testing. PLoS Comput Biol. 2017;13:1\u201310.","journal-title":"PLoS Comput Biol"},{"key":"1574_CR24","first-page":"5","volume":"5","author":"G Yu","year":"2024","unstructured":"Yu G. Thirteen years of clusterProfiler. Innovation. 2024;5:5\u20136.","journal-title":"Innovation"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande B, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15:2247\u201376.","journal-title":"Nat Protoc"},{"key":"1574_CR26","doi-asserted-by":"publisher","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303.metabolite.","DOI":"10.1101\/gr.1239303.metabolite"},{"key":"1574_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.1081889","volume":"13","author":"J Zhong","year":"2023","unstructured":"Zhong J, et al. Single-cell RNA sequencing reveals the molecular features of peripheral blood immune cells in children, adults and centenarians. Front Immunol. 2023;13:1\u201315.","journal-title":"Front Immunol"},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","volume":"53","author":"CC Robertson","year":"2021","unstructured":"Robertson CC, et al. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat Genet. 2021;53:962\u201371.","journal-title":"Nat Genet"},{"key":"1574_CR29","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00125-022-05657-x","volume":"65","author":"I Starskaia","year":"2022","unstructured":"Starskaia I, et al. Early DNA methylation changes in children developing beta cell autoimmunity at a young age. Diabetologia. 2022;65:844\u201360.","journal-title":"Diabetologia"},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20190617","volume":"39","author":"H Lian","year":"2019","unstructured":"Lian H, Cheng Y, Wu X. Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4. Biosci Rep. 2019;39:1\u201311.","journal-title":"Biosci Rep"},{"key":"1574_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105322","volume":"299","author":"A Sen","year":"2023","unstructured":"Sen A, Youssef S, Wendt K, Anakk S. Depletion of IQ motif-containing GTPase activating protein 2 (IQGAP2) reduces hepatic glycogen and impairs insulin signaling. J Biol Chem. 2023;299:105322.","journal-title":"J Biol Chem"},{"key":"1574_CR32","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.2337\/db13-1777","volume":"63","author":"RC Ferreira","year":"2014","unstructured":"Ferreira RC, et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes. 2014;63:2538\u201350.","journal-title":"Diabetes"},{"key":"1574_CR33","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/db13-1775","volume":"63","author":"H Kallionp\u00e4\u00e4","year":"2014","unstructured":"Kallionp\u00e4\u00e4 H, et al. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes. 2014;63:2402\u201314.","journal-title":"Diabetes"},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry A, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011;34:566\u201378.","journal-title":"Immunity"},{"key":"1574_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2022.156009","volume":"158","author":"N Nishiyama","year":"2022","unstructured":"Nishiyama N, Nakahashi-Oda C, Shibuya A. Interferon-\u03b2 promotes the survival and function of induced regulatory T cells. Cytokine. 2022;158:1\u20135.","journal-title":"Cytokine"},{"key":"1574_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s43018-023-00557-4","volume":"4","author":"A Javitt","year":"2023","unstructured":"Javitt A, et al. The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC. Nat Cancer. 2023;4:629\u201347.","journal-title":"Nat Cancer"},{"key":"1574_CR37","doi-asserted-by":"crossref","unstructured":"Mehdi AM, et al. A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes. JCI insight. 2018; 3: 0\u201313.","DOI":"10.1172\/jci.insight.98212"},{"key":"1574_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11306-014-0639-9","volume":"10","author":"B Vaitheesvaran","year":"2014","unstructured":"Vaitheesvaran B, et al. Role of the tumor suppressor IQGAP2 in metabolic homeostasis: possible link between diabetes and cancer. Metabolomics. 2014;10:920\u201337.","journal-title":"Metabolomics"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaut.2010.03.001","volume":"35","author":"LL Elo","year":"2010","unstructured":"Elo LL, et al. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling. J Autoimmun. 2010;35:70\u20136.","journal-title":"J Autoimmun"},{"key":"1574_CR40","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2337\/db17-0517","volume":"66","author":"ZUA Mollah","year":"2017","unstructured":"Mollah ZUA, et al. Granzyme a deficiency breaks immune tolerance and promotes autoimmune diabetes through a type i interferon-dependent pathway. Diabetes. 2017;66:3041\u201350.","journal-title":"Diabetes"},{"key":"1574_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0124927","volume":"10","author":"S Velaga","year":"2015","unstructured":"Velaga S, et al. Granzyme a is required for regulatory T-cell mediated prevention of gastrointestinal graft-versus-host disease. PLoS ONE. 2015;10:1\u20139.","journal-title":"PLoS ONE"},{"key":"1574_CR42","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jcb.22644","volume":"110","author":"Q Zhong","year":"2010","unstructured":"Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem. 2010;110:1306\u201313.","journal-title":"J Cell Biochem"},{"key":"1574_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24066007","author":"C Kourtidou","year":"2023","unstructured":"Kourtidou C, Tziomalos K. The role of histone modifications in the pathogenesis of diabetic kidney disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24066007.","journal-title":"Int J Mol Sci"},{"key":"1574_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4065382","author":"X Li","year":"2016","unstructured":"Li X, Li C, Sun G. Histone acetylation and its modifiers in the pathogenesis of diabetic nephropathy. J Diabetes Res. 2016. https:\/\/doi.org\/10.1155\/2016\/4065382.","journal-title":"J Diabetes Res"},{"key":"1574_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2023.105592","volume":"170","author":"A Aggarwal","year":"2023","unstructured":"Aggarwal A, Yadav B, Sharma N, Kaur R, Rishi V. Disruption of histone acetylation homeostasis triggers cognitive dysfunction in experimental diabetes. Neurochem Int. 2023;170:105592.","journal-title":"Neurochem Int"},{"key":"1574_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.201745566","volume":"19","author":"IK Mandemaker","year":"2018","unstructured":"Mandemaker IK, et al. DNA damage-induced replication stress results in PA 200-proteasome-mediated degradation of acetylated histones. EMBO Rep. 2018;19:1\u201315.","journal-title":"EMBO Rep"},{"key":"1574_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1326711","volume":"14","author":"JRN Lemos","year":"2023","unstructured":"Lemos JRN, Hirani K, von Herrath M. Immunological and virological triggers of type 1 diabetes: insights and implications. Front Immunol. 2023;14:1326711.","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"1574_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/pedi.12370","volume":"17","author":"H Hy\u00f6ty","year":"2016","unstructured":"Hy\u00f6ty H. Viruses in type 1 diabetes. Pediatr Diabetes. 2016;17(Suppl 2):56\u201364.","journal-title":"Pediatr Diabetes"},{"key":"1574_CR49","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1084\/jem.20080526","volume":"205","author":"GA Martins","year":"2008","unstructured":"Martins GA, Cimmino L, Liao J, Magnusdottir E, Calame K. Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J Exp Med. 2008;205:1959\u201365.","journal-title":"J Exp Med"},{"key":"1574_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.celrep.2018.09.016","volume":"25","author":"C Ogawa","year":"2018","unstructured":"Ogawa C, et al. Blimp-1 functions as a molecular switch to prevent inflammatory activity in Foxp3+ROR\u03b3t+ regulatory T cells. Cell Rep. 2018;25:19-28.e5.","journal-title":"Cell Rep"},{"key":"1574_CR51","first-page":"1","volume":"13","author":"H Guo","year":"2022","unstructured":"Guo H, et al. PRDM1 drives human primary T cell hyporesponsiveness by altering the T cell transcriptome and epigenome. Front Immunol. 2022;13:1\u201313.","journal-title":"Front Immunol"},{"key":"1574_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00125-012-2722-y","volume":"56","author":"MH Lin","year":"2013","unstructured":"Lin MH, et al. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells. Diabetologia. 2013;56:136\u201346.","journal-title":"Diabetologia"},{"key":"1574_CR53","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.4049\/jimmunol.1201966","volume":"189","author":"S Salehi","year":"2012","unstructured":"Salehi S, et al. B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17\u2013producing CD4+ T cells. J Immunol. 2012;189:5682\u201393.","journal-title":"J Immunol"},{"key":"1574_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23128","volume":"6","author":"E Acerbi","year":"2016","unstructured":"Acerbi E, et al. Continuous time Bayesian networks identify Prdm1 as a negative regulator of TH17 cell differentiation in humans. Sci Rep. 2016;6:1\u20137.","journal-title":"Sci Rep"},{"key":"1574_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4049\/jimmunol.1701697","volume":"202","author":"M Sun","year":"2019","unstructured":"Sun M, et al. ROR\u03b3t represses IL-10 production in Th17 cells to maintain their pathogenicity in inducing intestinal inflammation. J Immunol. 2019;202:79\u201392.","journal-title":"J Immunol"},{"key":"1574_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","volume":"44","author":"R Jain","year":"2016","unstructured":"Jain R, et al. Interleukin-23-induced transcription factor Blimp-1 promotes pathogenicity of T helper 17 cells. Immunity. 2016;44:131\u201342.","journal-title":"Immunity"},{"key":"1574_CR57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol. 2023;19:542\u201354.","journal-title":"Nat Rev Endocrinol"},{"key":"1574_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47918-w","author":"I Starskaia","year":"2024","unstructured":"Starskaia I, et al. Distinct cellular immune responses in children en route to type 1 diabetes with different first-appearing autoantibodies. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-47918-w.","journal-title":"Nat Commun"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-025-01574-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T12:01:58Z","timestamp":1767096118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-025-01574-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1186\/s13073-025-01574-x","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conformed to the principles of the Helsinki Declaration in the Ethics approval and consent to participate. The study protocol was approved by the ethics committee of the participating centers in Trial to Reduce Insulin Dependent Diabetes Mellitus (IDDM) in Genetically at Risk (TRIGR) cohort study [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}